Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

MUSTANG BIO, INC. (MBIO) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

MUSTANG BIO, INC. (MBIO), most recent 12 months reported: net loss $3.03M. Latest balance sheet on file: liquid cash $15.15M. From SEC filings. Others in Pharmaceutical Preparations: LARIMAR THERAPEUTICS, INC. · LANTERN PHARMA INC. · MAIA Biotechnology, Inc. · Veradermics, Inc · Moleculin Biotech, Inc. · MBX Biosciences, Inc. · MEDICUS PHARMA LTD. · Jyong Biotech Ltd.

Stock screener

Watchlist